The segmentation of genetic testing markets has been done in the report on the basis of
applications, diseases, and geographical regions.
Based on application, the genetic testing market is divided into Diagnostic Testing, Newborn
Screening, Prenatal Testing, Carrier Screening, and Others. Diagnostic testing and Newborn
screening are the major application areas of genetic testing industry. The large shares of these
applications can be attributed to presence of huge players in the segment, and to rising number of
genetic tests performed for this purpose. The Carrier Testing market is expected to witness the
highest growth during 2016-2022. This growth is likely to be driven by the huge population opting
for carrier screening of cystic fibrosis, exhibiting unprecedented rise in the US. The report provides
current and forecasted market for each of the application areas of Genetic Testing.
The major disease profiles/conditions for which Genetic Testing is used include Alzheimer's
Disease, Cystic Fibrosis, Cancer, Down Syndrome, and Others. Cancer accounts for largest share
amongst the diseases for which genetic testing is done. This large share can be attributed to the
rising prevalence of cancer, which is expected to increase as the global population ages.
Read Sample report of this Category:
http://www.radiantinsights.com/catalog/healthcare
Approximately 75-80% of all cancers are diagnosed in people aged 55 or older, and this pattern is
expected to increase by 2020. The report provides current and forecasted market for each of the
genetic conditions of Genetic Testing.
Moreover, the report also contains markets for the major regions including North America, Europe,
Asia Pacific, and Rest of the World. North America contributes the largest share in the global
genetic testing market, followed by Europe. Presence of major players, increased awareness and
higher disposable income, are some of the prominent factors that have led to North America being
the market leader. The Asia-Pacific market is expected to witness the highest growth during 2016-
2022. The major reasons for the high growth are the increasing per capita income and gradual
development of healthcare sector in countries, such as India and China . North America and Europe
are expected to grow at modest rate due to launch of new and innovative products in these
market.
The company profiles segment in this report is entirely devoted to profiling leading companies of
the genetic testing industry including some major players like Abbott Laboratories, Roche
Diagnostics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Hologic, Inc., Cepheid, Agilent
Technologies and QIAGEN. This segment provides you access to the new launched products, recent
developments, and strengths and weaknesses of these companies to deliver a clear
understanding/view of the competitive landscape. Overall, the report will prove to be a complete
source of knowledge and analysis for clients and potential investors.
Table of Contents
Follow Us: